» Articles » PMID: 38911063

Photodynamic Therapy for Cancer: Mechanisms, Photosensitizers, Nanocarriers, and Clinical Studies

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2024 Jun 24
PMID 38911063
Authors
Affiliations
Soon will be listed here.
Abstract

Photodynamic therapy (PDT) is a temporally and spatially precisely controllable, noninvasive, and potentially highly efficient method of phototherapy. The three components of PDT primarily include photosensitizers, oxygen, and light. PDT employs specific wavelengths of light to active photosensitizers at the tumor site, generating reactive oxygen species that are fatal to tumor cells. Nevertheless, traditional photosensitizers have disadvantages such as poor water solubility, severe oxygen-dependency, and low targetability, and the light is difficult to penetrate the deep tumor tissue, which remains the toughest task in the application of PDT in the clinic. Here, we systematically summarize the development and the molecular mechanisms of photosensitizers, and the challenges of PDT in tumor management, highlighting the advantages of nanocarriers-based PDT against cancer. The development of third generation photosensitizers has opened up new horizons in PDT, and the cooperation between nanocarriers and PDT has attained satisfactory achievements. Finally, the clinical studies of PDT are discussed. Overall, we present an overview and our perspective of PDT in the field of tumor management, and we believe this work will provide a new insight into tumor-based PDT.

Citing Articles

Hybrid Nanoplatforms Based on Photosensitizers and Metal/Covalent Organic Frameworks for Improved Cancer Synergistic Treatment Nano-Delivery Systems.

Magadla A Molecules. 2025; 30(4).

PMID: 40005193 PMC: 11858586. DOI: 10.3390/molecules30040884.


Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions.

Hasan A, Cavalu S, Kira A, Hamad R, Abdel-Reheim M, Elmorsy E Int J Nanomedicine. 2025; 20():741-770.

PMID: 39845772 PMC: 11752831. DOI: 10.2147/IJN.S502833.


Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Nazarenko A, Shkirdova A, Orlova E, Biryukova Y, Vorovitch M, Kolyasnikova N Int J Mol Sci. 2024; 25(23).

PMID: 39684289 PMC: 11640982. DOI: 10.3390/ijms252312578.


Unraveling Microviscosity Changes Induced in Cancer Cells by Photodynamic Therapy with Targeted Genetically Encoded Photosensitizer.

Shimolina L, Khlynova A, Elagin V, Bureev P, Sherin P, Kuimova M Biomedicines. 2024; 12(11).

PMID: 39595116 PMC: 11591579. DOI: 10.3390/biomedicines12112550.


Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy.

Yu Z, Zheng M, Fan H, Liang X, Tang Y Mol Biomed. 2024; 5(1):49.

PMID: 39417901 PMC: 11486887. DOI: 10.1186/s43556-024-00209-8.


References
1.
Wu M, Gu M, Leung J, Li X, Yuan Y, Shen C . A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses. Small. 2021; 17(30):e2101770. PMC: 8420407. DOI: 10.1002/smll.202101770. View

2.
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

3.
Chen J, Fan T, Xie Z, Zeng Q, Xue P, Zheng T . Advances in nanomaterials for photodynamic therapy applications: Status and challenges. Biomaterials. 2020; 237:119827. DOI: 10.1016/j.biomaterials.2020.119827. View

4.
Makuch S, Drozdz M, Makarec A, Ziolkowski P, Wozniak M . An Update on Photodynamic Therapy of Psoriasis-Current Strategies and Nanotechnology as a Future Perspective. Int J Mol Sci. 2022; 23(17). PMC: 9456335. DOI: 10.3390/ijms23179845. View

5.
Imberti C, Zhang P, Huang H, Sadler P . New Designs for Phototherapeutic Transition Metal Complexes. Angew Chem Int Ed Engl. 2019; 59(1):61-73. PMC: 6973108. DOI: 10.1002/anie.201905171. View